Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: A voltammetric approach in the rat

Brain Research

Volumn 736, Issue 1-2, 1996, Pages 82-90

  Marinesco, Stéphane ^a   Poncet, Ludovic ^a   Debilly, Gabriel ^a   Jouvet, Michel ^a   Cespuglio, Raymond ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

5 hydroxyindoleacetic acid; electrochemistry; monoamine oxidase inhibitor; monoamine oxidase type A or B; rat; serotonin

Indexed keywords

2 (3,4 DIMETHOXYPHENYL) 3 FLUOROALLYLAMINE; 5 HYDROXYINDOLEACETIC ACID; CLOMIPRAMINE; CLORGYLINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM; SEROTONIN UPTAKE;

EID: 0030583630     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00681-6     Document Type: Article

References (42)

1. [1] Anderson, E., McFarland, D. and Kimelberg, H., Serotonin uptake by astrocytes in situ, Glia, 6 (1992) 154-158.
2. [2] Celada, P. and Artigas, F., Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues, J. Neurochem., 61 (1993) 2191-2198.
3. [3] Cespuglio, R., Sarda, N., Gharib, A., Faradji, H. and Chastrette, N., Differential pulse voltammetry in vivo with working carbon fiber electrodes: 5-hydroxyindole compounds or uric acid detection?, Exp. Brain Res., 64 (1986) 589-595.
4. [4] Cespuglio, R., Sarda, N., Gharib, A., Faradji, H., Chastrette, N., Houdouin, F., Rampin, C. and Jouvet, M., Voltammetric detection of the release of 5-hydroxyindole compounds throughout the sleep-waking cycle of the rat, Exp Brain Res., 80 (1990) 121-128.
5. 3H-paroxetine binding sites in rat brain, J. Pharmacol. Toxic. Meth., 21 (1992) 209-216.
6. [6] Cooke, D.J. and Hole, D.J., The aetiological importance of stressful events, Br. J. Psychiat., 143 (1993) 397-400.
7. [7] De Simoni, M.G., De Luigi, A., Clavenna, A. and Manfridi, A., In vivo studies on the enhancement of serotonin reuptake by tianeptine, Brain Res., 574 (1992) 93-97.
8. 3H]citalopram binding in the rat and human brain: species differences and relationship to serotonin innervation patterns, Brain Res., 591 (1992) 181-197.
9. [9] Fattacini, C.M., Bolanos-Jiménez, F., Gozlan, H. and Hamon, M., Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in rat brain, Neuropharmacology, 29 (1989) 1-8.
10. [10] Fitzgerald, L., Kaplinsky, L. and Kimelberg, H., Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures, J. Neurochem., 55 (1990) 2008-2014.
11. [11] Fowler, C. and Tipton, K., Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain, J. Neurochem., 38 (1992) 733-736.
12. [12] Fujita, M., Shimada, S., Maeno, H., Nishimura, T. and Toyama, M., Cellular localization of serotonin transporter mRNA in the rat brain, Neurosci. Lett., 162 (1993) 59-62.
13. [13] Garrick, N, and Murphy, D., Monoamine oxidase type A: difference in selectivity towards L-norepinephrine compared to serotonin, Biochem. Pharmacol., 31 (1982) 4061-4066.
14. [14] Gu, X.F. and Azmitia, E.C., Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons, Eur. J. Pharmacology, 235 (1993) 51-57.
15. [15] Houdouin, F., Cespuglio, R., Gharib, A., Sarda, N. and Jouvet, M., Time-course variations induced by pargyline on the 5-hydroxyindole compounds measured in the nucleus raphe dorsalis and in blood: a voltammetric and HPLC approach in the rat, Neurosci. Lett., 117 (1990) 218-223.
16. [16] Houdouin, F., Cespuglio, R., Gharib, A., Sarda, N. and Jouvet, M., Detection of the release of 5-hydroxyindole compounds in the hypothalamus and the n. raphe dorsalis throughout the sleep-waking cycle and during stressful situations in the rat, Exp. Brain Res., 85 (1991) 153-162.
17. [17] Johnston, J.P., Some observations upon a new inhibitor of monoamine oxidase in brain tissue, Biochem. Pharmacol., 17 (1968) 1285.
18. [18] Kato, T., Dong, B., Ishii, K. and Kinemuchi, H., Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats, J. Neurochem., 46 (1986) 1277-1282.
19. [19] Kimelberg, H.K. and Katz, D.M., High-affinity uptake of serotonin into immunocytochemically identified astrocytes, Science, 228 (1985) 889-891.
20. [20] Kimelberg, H.K., Serotonin uptake into astrocytes and its implications. In N.N. Osborne and M. Hamon (Eds), Neuronal Serotonin, J. Wiley, New York, 1988, pp. 347-365.
21. [21] Kitahama, K., Arai, R., Maeda, T. and Jouvet, M., Demonstration of monoamine oxidase type B in serotonergic neurons and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique, Neurosci. Lett., 71 (1986) 19-24.
22. [22] Koe, K., Weissman, A., Welch, W. and Browne, R., Sertraline, a new uptake inhibitor with selectivity for serotonin, J. Pharmacol. Exp. Ther., 226 (1983) 686-700.
23. [23] Kumugae, Y., Matsui, Y. and Iwata, N., Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359, Jpn. J. Pharmacol., 55 (1991) 121-128.
24. [24] Lesch, K.P., Aulakh, C.S., Wolozin, B.L., Tolliver, T.J., Hill, J.L. and Murphy, D.L., Regional brain expression of serotonin transporter messenger RNA and its regulation by reuptake inhibiting antidepressants, Mol. Brain Res., 17 (1993) 31-35.
25. [25] Leonardi, E.T.K., Efrain, M.S. and Azmitia, C., MDMA (Ecstasy) inhibition of MAO type A and type B: comparison with fenfluramine and fluoxetine, Neuropsychopharmacology, 10 (1994) 231-238.
26. [26] Levitt, P., Pintar, J. and Breakfield, X., Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons, Proc. Natl. Acad. Sci. USA, 79 (1982) 6385-6389.
27. [27] Lichtensteiger W., Mutzner U. and Langeman H. (1967) Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines, J. Neurochem. 14, 489-497.
28. [28] Manfridi, A., Clavenna, A. and De Simoni, M.G., Serotonin uptake inhibition: in vivo effects of sertraline in rats, Neurosci. Lett., 136 (1993) 69-72.
29. [29] Magistretti, P.J., Peptides et système nerveux central, Médecine et Hygiène, 45 (1987) 1250-1257.
30. [30] Marsden, C.A., Joseph, M.H., Kruk, N.T., Maidment, N.T., O'Neill, R.D., Shenk, J.O. and Stamford, J.A., In vivo voltammetry -present electrodes and methods, Neuroscience, 25 (1988) 389-400.
31. [31] Moon, C.A.L., Jago, W., Wood, K. and Doogan, D.P., A double blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety, General Practice, 8 (1994) 171-176.
32. [32] O'Neill, R.D., Microvoltammetric techniques and sensors for monitoring neurochemical dynamics in vivo. Analyst, 119 (1994) 767-779.
33. [33] Palfreyman, M.G., Zreika, M., McDonald, I., Fozard, J.R. and Bey P., MDL 72145, an irreversible inhibitor of MAO B, L'Encéphale, 9 (1983) A3.
34. [34] Paxinos, G. and Watson, P., The Rat Brain in Stereotaxic Coordinate, Academic Press, New York/Paris/Tokyo/Sydney, 1986, p. 85.
35. [35] Puig, S., Rivot, J.P. and Besson, J.M., Effects of tianeptine on 5-hydroxyindoles and on the morphine-induced increase in 5-HT metabolism at the medullary dorsal horn level as measured by in vivo voltammetry in freely moving rats. Brain Res., 600 (1993) 219-224.
36. [36] Reinhard, J.F. and Wurtman R.J., Levels and the release of serotonin into brain synapses, Life Sci., 21 (1977) 1741-1746.
37. [37] Shaskan, E.G. and Snyder, S.H., Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake, J. Pharmacol. Exp. Ther., 175 (1970) 404-497.
38. [38] Snyder, R.S., Kuhar, M.J., Green, A.I., Coyle, J.T. and Shaskin, E.G., Uptake and subcellular localization of neurotransmitters in the brain, Int. Rev. Neurobiol., 13 (1970) 127-158.
39. [39] Small, D.H., Acethylcholinesterases: zymogens of neuropetides processing enzymes?. Neuroscience, 29 (1989) 241-249.
40. [40] Yang, H.Y.T. and Neff, N.H., ß-Phenethylamine: a specific substrate for type B monoamine oxidase of brain, J. Pharmacol. Exp. Ther., 187 (1973) 365-371.
41. [41] Yu, P. and Hertz, L., Type A and B monoamine oxidaze in glial cells in long-term culture, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 7 (1983) 687-690.
42. [42] Zieglgänsberger, W., Dodt, H.U., Deisz, R. and Pawelzik, H., Peptides in Neurotransmission. In K. Fuxe and L.F. Agnati (Eds), Transmission in the Brain, Raven Press, New York, 1991, pp. 371-379.